Viral Exanthems: Clinical Presentation and Management

Causes and Clinical Presentation

Human herpesvirus 6 (HHV-6B) and HHV-7 are primary causes of exanthem subitum (roseola infantum), with approximately 90% of children infected by age 1 and nearly 100% by age 3 3
Enteroviruses (coxsackievirus and echovirus) are common causes of viral exanthems that can present with petechial manifestations 2
Fever is typically the initial symptom, often high-spiking (39-40°C) and may persist for several days before rash appearance 4
Associated symptoms may include headache, malaise, myalgia, and upper respiratory symptoms 5
In roseola, high fever typically lasts 3-5 days and resolves abruptly as the rash appears 3
The American Heart Association, as reported in Circulation, notes that fever control and adequate hydration are important in managing symptoms 4
The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, recommends considering laboratory testing in immunocompromised patients 3

The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, notes that bacterial infections such as meningococcemia, Rocky Mountain Spotted Fever, scarlet fever, and streptococcal pharyngitis should be considered in the differential diagnosis 1, 5
The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, also notes that other tickborne diseases should be considered in the differential diagnosis 7, 8
The American Heart Association, as reported in Circulation, notes that drug hypersensitivity reactions, Kawasaki disease, and Stevens-Johnson syndrome should be considered in the differential diagnosis 1, 4
Serological tests for specific viral antibodies (IgM, IgG) and PCR detection of viral DNA/RNA in blood, throat swabs, or skin lesions can be used for laboratory confirmation 6, 3
A complete blood count may show characteristic patterns (e.g., leukopenia in certain viral infections) 5

The American Academy of Pediatrics, as reported in Praxis Medical Insights, notes that antiviral therapy is generally not indicated for most common viral exanthems in immunocompetent hosts 3
The Infectious Diseases Society of America, as reported in Clinical Infectious Diseases, notes that influenza-associated exanthems may benefit from early neuraminidase inhibitor therapy if identified within 48 hours of symptom onset 6
The Centers for Disease Control and Prevention, as reported in MMWR Recommendations and Reports, recommends vaccination against measles, mumps, rubella, and varicella to prevent viral exanthems 3
Hand hygiene and respiratory etiquette can help reduce transmission, although prevention of exposure is generally not feasible for common viral exanthems due to their ubiquity 3